Pancreatic Cystic Neoplasms Rarely Turn Cancerous Pancreatic Cystic Neoplasms Rarely Turn Cancerous
Individuals with intraductal papillary mucinous neoplasms that lack ' worrisome or high-risk features ' have no greater risk of pancreatic cancer than individuals without IPMNs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

New Column: Practical AI With Arturo Loaiza-Bonilla New Column: Practical AI With Arturo Loaiza-Bonilla
An expert on artificial intelligence and precision medicine in cancer care introduces his new column.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Avoid Anti-HER2 Cancer Therapies During Pregnancy Avoid Anti-HER2 Cancer Therapies During Pregnancy
Women with HER2-positive breast cancer who receive HER2-targeted therapies during pregnancy face a higher risk for severe adverse outcomes to their fetus or newborn, new research indicates.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Investigates Secondary Cancers From CAR T-Cell Therapies FDA Investigates Secondary Cancers From CAR T-Cell Therapies
The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19 –directed CAR T-cell immunotherapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news